Any Culture. Any User. Anywhere.
- Consistent results across instruments, users and sites
- Use with Via2-Cassette™ to eliminate human error
- Monitor production runs with DebrisIndex™
- Increased cell counting range: No more dilutions
- Scalable system with 21 CFR Part 11/GMP-ready software
The NucleoCounter® NC-202™ automated cell counter is the most precise on the market. Our 3rd generation cassette-based instrument features improved hardware and new NC-View™ software. The combined inter-operator/inter-instrument variation is typically 5 – 10%. This means you get identical results with any cell sample, recorded by any user, anywhere in the world.
The DebrisIndex™ feature measures culture debris build-up. Debris negatively affects downstream filtering and purifications steps, so directly measuring debris facilitates better process development parameters. Learn more about DebrisIndex™.
The NC-View™ software is compatible with 21 CFR Part 11/GMP guidelines and can be integrated into your clinical workflow.
The disposable Via2-Cassette™ combined with the NucleoCounter® NC-202™ automated cell counter create a closed cell counting system, helping you stay protected when handling samples. No pipettes, no exposure to (toxic) reagents, and minimal clean-up make the NucleoCounter® system a safe option.
How Precise Are Your Cell Counts?
A Guide to Validating a Cell Counting Method Presenter: Annemieke Karyotis, PhD / Field Application Scientist Do your cell counts vary at high and ...
Dead or Alive? Is Viability Alone Enough?
Cell Count and Viability in Cell Therapy Presenter: Greg Fendley, PhD / Senior Field Application Scientist A reliable cell count and viability is c...
Science Talk: Fast-Tracking a COVID-19 Vaccine
Developing a Vaccine with VLP Technology Join us for this Science Talk on fast tracking a COVID 19 vaccine through its developmental pipeline using...
Tech Note: NucleoCounter® NC-202™ Performance Data
Tech note: LED Considerations for NucleoCounter® NC-202™
Manufacturing a COVID-19 Vaccine
The Edward Jenner Institute at the University of Oxford is at the forefront in the battle against COVID 19. They are producing the novel peptide ba...
Inducing Apoptosis in Colorectal & Ovarian Cancers
Dr. Farideh Javid commenced her research at the University of Huddersfield in 2008 as a Senior Lecturer and is currently Reader in Pharmacology. He...